Autoimmune Diseases
Conference Coverage
Bloating. Flatulence. Think SIBO
Conference Coverage
VIDEO: Cannabinoids in dermatology
SAN DIEGO – “Our skin is chock full of cannabinoids; chock full of expression of cannabinoid receptors.”
Conference Coverage
VIDEO: Considering systemic disease in dermatology patients
SAN DIEGO – “The idea is really to start to try to get our dermatology colleagues thinking more systemically and outside of just the skin.”
Conference Coverage
VIDEO: PPACMAN aims to advance the combined rheum-derm clinic approach in the community
SAN DIEGO - The idea behind starting PPACMAN the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Networkwas to form clinics at...
From the Journals
ANA assay results differ widely in established lupus patients
Study results call into question the use of assays to determine trial eligibility and their role in clinical practice.
From the Journals
Majority of lupus patients lack eye exam around the start of hydroxychloroquine
Sociodemographic variation seen in Medicaid population study.
From the Journals
JAK inhibitors look good for severe alopecia areata treatment
Adolescents may benefit the most from this new therapy.
From the Journals
Predictors may help to spot risk for hydroxychloroquine nonadherence
A detailed look at the trajectories of patients who stop, continue, or never start the drug.
From the Journals
Cases link vitiligoid lichen sclerosus and darker skin
High-potency topical steroids and/or calcineurin inhibitors resolved symptoms in all cases, but depigmentation remained.
Conference Coverage
Neutrophilic urticarial dermatosis is usually misdiagnosed
GENEVA – This skin eruption is “underdiagnosed and overtreated” in SLE patients.
From the Journals
Rituximab tackles relapse of severe, difficult-to-treat pemphigus
Drug succeeds as a single, long-term maintenance therapy, with a better risk-to-benefit ratio than corticosteroids.